1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Central America Pharmaceuticals and Healthcare Report Q3 2015

Central America Pharmaceuticals and Healthcare Report Q3 2015

  • May 2015
  • -
  • Business Monitor International
  • -
  • 58 pages

Includes 3 FREE quarterly updates

BMI View:
Favourable tax incentives, continued demand for both generic and patented medicines, andregional anti-counterfiet measures solidify Central America's revenue generating opportunities formultinational pharmaceutical companies in coming years. Despite political instability in some areas of theregion, Central America's medicine consumption will continue to grow in 2015.
Headline Expenditure Projections
- Pharmaceuticals: USD3.7bn in 2014 to USD3.9bn in 2015; +4.1%. Our forecast has been maintainedsince Q215.- Healthcare: USD16.8bn in 2014 to USD17.8bn in 2015; +5.1%. Our forecast has been revised upwardssince Q215 due to revised historical data.

Table Of Contents

Central America Pharmaceuticals and Healthcare Report Q3 2015
BMI Industry View ...... 7
SWOT ............ 9
SWOT .............. 9
Industry Forecast ..... 10
Pharmaceutical Market Forecast ....... 10
Table: Central America Pharmaceutical Sales, Historic Data And Forecasts . 12
Guatemala ..... 12
Table: Guatemala Pharmaceutical Sales Forecasts . . . . 12
Costa Rica ..... 13
Table: Costa Rica Pharmaceutical Sales Forecasts . . . . 13
El Salvador .... 13
Table: El Salvador Pharmaceutical Sales Forecasts . . . 14
Honduras ...... 14
Table: Honduras Pharmaceutical Sales Forecasts . . . . . 14
Panama ......... 14
Table: Panama Pharmaceutical Sales Forecasts . 15
Nicaragua ..... 15
Table: Nicaragua Pharmaceutical Sales Forecasts . . . . 15
Healthcare Market Forecast ............. 16
Table: Central America Healthcare Expenditure Trends, Historical Data And Forecasts 17
Guatemala ..... 17
Table: Guatemala Healthcare Expenditure Forecasts . 18
Costa Rica ..... 18
Table: Costa Rica Healthcare Expenditure Forecasts . 18
El Salvador .... 18
Table: El Salvador Healthcare Expenditure Forecasts 19
Panama ......... 19
Table: Panama Healthcare Expenditure Forecasts . . . . 19
Honduras ...... 19
Table: Honduras Healthcare Expenditure Forecasts . . 20
Nicaragua ..... 20
Table: Nicaragua Healthcare Expenditure Forecasts . . 20
Pharmaceutical Trade Forecast ........ 21
Guatemala ..... 23
Table: Guatemala Pharmaceutical Trade Data And Forecasts (USDmn) . . . . . 23
Costa Rica ..... 23
Table: Costa Rica Pharmaceutical Trade Data And Forecasts (USDmn) . . . . . 23
El Salvador .... 24
Table: El Salvador Pharmaceutical Trade Data And Forecasts (USDmn) . . . . 24
Panama ......... 24
Table: Panama Pharmaceutical Trade Data And Forecasts (USDmn) . . 25
Honduras ...... 25
Table: Honduras Pharmaceutical Trade Data And Forecasts (USDmn) 25
Nicaragua ..... 26
Table: Nicaragua Pharmaceutical Trade Data And Forecasts (USDmn) 26
Industry Risk Reward Ratings 27
Americas Risk/Reward Index ............ 27
Central America Risk/Reward Index ... 32
Rewards ........ 33
Risks ............. 33
Industry Trends And Developments ..... 34
Epidemiology . 34
Healthcare Sector .......... 35
Guatemala ..... 36
Costa Rica ..... 37
El Salvador .... 38
Panama ......... 39
Honduras ...... 39
Nicaragua ..... 40
Clinical Trials 41
Regulatory Development ........ 43
Intellectual Property Regime ........... 43
Costa Rica ..... 44
El Salvador .... 45
Honduras ...... 45
Nicaragua ..... 46
Guatemala ..... 46
Competitive Landscape .......... 47
Company Profile ....... 48
Ancalmo Internacional ..... 48
Donovan Werke 50
Glossary ..... 52
Methodology ............. 54
Pharmaceutical Expenditure Forecast Model .... 54
Healthcare Expenditure Forecast Model ........... 54
Notes On Methodology .... 55
Risk/Reward Index Methodology ...... 56
Index Overview .............. 57
Table: Pharmaceutical Risk/Reward Index Indicators . 57
Indicator Weightings ...... 58

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
OpportunityAnalyzer: Huntington’s Disease - Opportunity Analysis and Forecast to 2024

OpportunityAnalyzer: Huntington’s Disease - Opportunity Analysis and Forecast to 2024

  • $ 9 495
  • Industry report
  • May 2016
  • by Global Data

OpportunityAnalyzer: Huntington’s Disease - Opportunity Analysis and Forecast to 2024 Summary Huntington’s Disease (HD) is a rare, autosomal-dominant, neurodegenerative disorder, characterized by impaired ...

Asthma Pricing, Reimbursement, and Access

Asthma Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • May 2016
  • by Datamonitor Healthcare

Growth in the asthma market will be fueled by the introduction of new and expensive biologics, but companies will have to navigate access restrictions imposed by payers concerned about budget impact. This ...

Multiple Myeloma Pricing, Reimbursement, and Access

Multiple Myeloma Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • May 2016
  • by Datamonitor Healthcare

Growth in the multiple myeloma market will be spurred by the approval of novel drugs and the increasing role of combination therapy, but risk-sharing agreements will be key to entry into increasingly restrictive ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.